Vaccine stocks in focus as RFK Jr., a notable vaccine skeptic and President Trump’s nominee to lead the HHS, faces a Senate ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Investing.com - Healthcare and vaccine stocks are likely to be in the spotlight on Wednesday as Robert F. Kennedy Jr., U.S. President Donald Trump's pick to run the Department of Health and Human ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Healthcare sector shows strong performance in January amid signs of a brighter 2025, according to analysts. Read more here.

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) Department of Defense (DoD) for ...

Robert F. Kennedy Jr. said he wasn’t antivaccine as senators pressed on his past remarks, in the first of two days of ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best depressed stocks ...

Some more data is coming in on just how extraordinary Monday's markets moves were. Benedek Voros, director of index ...

Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...